Title: Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a
population-based study
Version: 1 Date: 01 May 2021
Reviewer:  Nahum Méndez-sánchez
Reviewer's report:
Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a
population-based study
This is an interesting study. Here there is nothing new compare with the results of previous
studies. But the sample size is big. I suggest to improve the discussion section.
Comments
What about other liver function liver tests?
What about the role of gene polymorphisms in for the development of HCC in NAFLD non
cirrhotic patients.
What about the treatment in NAFLD non cirrhotic compare with cirrhotic patients?
What about the mortality in NAFLD non cirrhotic patients?
What about the recurrence in NAFLD non cirrhotic patients?
Title: Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a
population-based study
Version: 1 Date: 01 May 2021
Reviewer:  Nahum Méndez-sánchez
Reviewer's report:
Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a
population-based study
This is an interesting study. Here there is nothing new compare with the results of previous
studies. But the sample size is big. I suggest to improve the discussion section.
Comments
What about other liver function liver tests?
What about the role of gene polymorphisms in for the development of HCC in NAFLD non
cirrhotic patients.
What about the treatment in NAFLD non cirrhotic compare with cirrhotic patients?
What about the mortality in NAFLD non cirrhotic patients?
What about the recurrence in NAFLD non cirrhotic patients?
Please review this paper.
user
Title: Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a
population-based study
Version: 1 Date: 01 May 2021
Reviewer:  Nahum Méndez-sánchez
Reviewer's report:
Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a
population-based study
This is an interesting study. Here there is nothing new compare with the results of previous
studies. But the sample size is big. I suggest to improve the discussion section.
Comments
What about other liver function liver tests?
What about the role of gene polymorphisms in for the development of HCC in NAFLD non
cirrhotic patients.
What about the treatment in NAFLD non cirrhotic compare with cirrhotic patients?
What about the mortality in NAFLD non cirrhotic patients?
What about the recurrence in NAFLD non cirrhotic patients?
assistant